Cargando…
Can Gram-Negative Bacteria Develop Resistance to Antimicrobial Blue Light Treatment?
Antimicrobial blue light (aBL) treatment is considered low risk for the development of bacterial resistance and tolerance due to its multitarget mode of action. The aim of the current study was to demonstrate whether tolerance development occurs in Gram-negative bacteria. We evaluated the potential...
Autores principales: | Rapacka-Zdonczyk, Aleksandra, Wozniak, Agata, Kruszewska, Beata, Waleron, Krzysztof, Grinholc, Mariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583887/ https://www.ncbi.nlm.nih.gov/pubmed/34769009 http://dx.doi.org/10.3390/ijms222111579 |
Ejemplares similares
-
Development of Staphylococcus aureus tolerance to antimicrobial photodynamic inactivation and antimicrobial blue light upon sub-lethal treatment
por: Rapacka-Zdonczyk, Aleksandra, et al.
Publicado: (2019) -
Development of Antimicrobial Phototreatment Tolerance: Why the Methodology Matters
por: Rapacka-Zdonczyk, Aleksandra, et al.
Publicado: (2021) -
Antimicrobials Are a Photodynamic Inactivation Adjuvant for the Eradication of Extensively Drug-Resistant Acinetobacter baumannii
por: Wozniak, Agata, et al.
Publicado: (2019) -
Factors Determining the Susceptibility of Bacteria to Antibacterial Photodynamic Inactivation
por: Rapacka-Zdończyk, Aleksandra, et al.
Publicado: (2021) -
Combined Antimicrobial Blue Light and Antibiotics as a Tool for Eradication of Multidrug-Resistant Isolates of Pseudomonas aeruginosa and Staphylococcus aureus: In Vitro and In Vivo Studies
por: Woźniak, Agata, et al.
Publicado: (2022)